The Oncology Institute Inc. (NASDAQ: TOI) announced that its Chief Medical Officer Yale D. Podnos will participate in a panel discussion at the APG Spring Conference on May 28 in San Diego. The session titled "Engaging More Specialists in Value-Based Care" will bring together healthcare leaders to discuss the role of specialists in value-based care.

Podnos will share insights on oncology's role in improving outcomes, reducing costs, and advancing value-based care delivery during the conference panel.

"Specialists play a critical role in delivering high-quality, coordinated care while helping improve outcomes and reduce the total cost of care," Podnos stated. "As oncology continues to evolve, value-based models create opportunities to enhance the patient experience, maximize quality of life and survival outcomes, and improve care quality and patient safety."

The Oncology Institute operates as a value-based oncology group with over 180 employed and affiliate clinicians across more than 100 clinics and affiliate locations in five states. The company serves approximately 1.9 million patients and offers services including clinical trials and transfusions in community settings.

Founded in 2007, the company went public and trades on NASDAQ under the ticker symbol TOI. The information was disclosed in a company press release.